Last reviewed · How we verify

NCT04961372

Socio-psychological Status of Healthcare Workers During SARS-CoV2 Pandemic

Completed Last updated 23 March 2022
What this trial tests

trial testing Survey in Depression, Anxiety in 333 participants. Completed in 30 September 2021.

Timeline
1 March 2021
Primary endpoint
1 September 2021
30 September 2021

Quick facts

Lead sponsorErzincan University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment333
Start date1 March 2021
Primary completion1 September 2021
Estimated completion30 September 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Erzincan University

Who can join

Adults 18 to 65, any sex, with Depression, Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of our study is to investigate the presence of depression, anxiety and fear in healthcare workers during the SARS-CoV2 pandemic process, to evaluate their work and social life situations, as well as to evaluate the perspectives of the entire population towards hospital admission, surgery decision and vaccination.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Survey

Trials testing the same drug.

Other recruiting trials for Depression, Anxiety

Currently open trials in the same condition.

Other Erzincan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04961372.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing